Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis.
OBJECTIVE: To compare the efficacy of the lipido-sterolic extract of Serenoa repens, Permixon, to that of the alpha-blocker, tamsulosin, in the treatment of severe low urinary tract symptoms (LUTS) of benign prostatic hyperplasia (BPH). METHODS: In a 12-month, double-blind, randomized study that sh...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2004
|
Search Result 1
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients - Permal study sub-set analysis
Published 2004
Conference item
Search Result 2
![[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].](/Cover/Show?author=Debruyne%2C+F&callnumber=&size=medium&title=%5BEvaluation+of+the+clinical+benefit+of+Permixon+and+tamsulosin+in+severe+BPH+patients--PERMAL+study+subset+analysis%5D.&recordid=oxford-uuid%3A7b59aa46-123b-48ee-ae33-413408c20c22&source=Solr)
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].
Published 2004
Journal article
Search Result 3
Evaluation of the clinical benefit of permixon® and tamsulosin in severe BPH patients - PERMAL study subset analysis
Published 2004
Journal article